Jeff Yass’s ArriVent BioPharma AVBP Stock Holding History
Bought
Maintained
Sold
Other funds holding AVBP
IAM
Jeff Yass's AVBP Position: Q3 2026 in Review
Jeff Yass sold out of ArriVent BioPharma (AVBP) in Q3 2026, closing a stake of 28,582 shares — an estimated $876K sold.
Jeff Yass first reported a position in AVBP in Q4 2024 and held it in 6 quarters. The position peaked at $4.89M in Q4 2025. 153 funds tracked by Wall St. Rank hold AVBP as of Q3 2026.
- Jeff Yass reported no remaining ArriVent BioPharma position as of Q3 2026 after selling out during the quarter.
- Jeff Yass sold 28,582 ArriVent BioPharma shares in Q3 2026, an estimated $876K.
- Jeff Yass first reported a position in ArriVent BioPharma in Q4 2024 and held it in 6 quarters.
- Jeff Yass's ArriVent BioPharma position peaked at $4.89M in Q4 2025.
- 153 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.